Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Nutrisystem, Inc. (NASDAQ: NTRI), the number one home delivery weight loss company, announced today that it is revamping its programs by incorporating its highest scoring, best tasting fresh frozen gourmet foods into all of its weight loss plans at the lowest price in the Company’s history. Part of Nutrisystem’s “Hooray You! New You Revolution” initiative is to empower and celebrate the success of its members, and with these significant changes it will make Nutrisystem® weight loss programs more accessible to a wider audience than ever before.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nutrisystem/47901/
Are you ready to rock? It’s show time as Hasbro Inc.’s (NASDAQ: HAS) iconic PLAYSKOOL brand introduces the LET’S ROCK! ELMO interactive plush, the most innovative Elmo toy yet. Joined by music industry veteran and Grammy Award-winning producer Randy Jackson, LET’S ROCK! ELMO made his official debut at a private event yesterday at the Empire Hotel in New York, NY. Known for his ability to guide the next generation of music superstars into the spotlight, Jackson was on hand to offer advice as LET’S ROCK! ELMO takes the stage at retail this fall. The truly interactive LET’S ROCK! ELMO plush character sings, plays instruments, and invites little musicians to rock out with him!
To view Multimedia News Release, go to http://www.multivu.com/mnr/52202-randy-jackson-joins-hasbro-playskool-for-let-s-rock-elmo-launch
Fisher-Price®, Inc., a subsidiary of Mattel, Inc. (Nasdaq: MAT), and Disney Consumer Products rocked the house at New York Toy Fair for the debut of the innovative and engaging Rock Star™ Mickey. more... Last year's hugely popular Dance Star Mickey brought the iconic character to life for a new generation of fans as he soared to the top of kids' wish lists and was among the hottest toys of the holiday season. This year the excitement moves from the dance floor to the rock stage for a truly authentic rock star experience for kids.
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
The battle between the X-Men and Brotherhood of Mutants rages on – and your choices will shape the fate of the world! Available today at retail stores nationwide, Marvel Entertainment, LLC and Activision Publishing, Inc.’s (Nasdaq: ATVI) X-Men™ Destiny places gamers into the role of a young mutant just discovering their newfound powers; where the choices they make and alliances they forge determine which side of the mutant cause will reign supreme. X-Men Destiny gives players three all-new mutants from which to pick, and an original story penned by acclaimed Marvel writer Mike Carey, delivering an action/RPG experience where players have ultimate customization of their mutant’s powers, development and “destiny.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/52109-activision-marvel-release-x-men-destiny-action-rpg-video-game
Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/
Walgreens (NYSE, NASDAQ: WAG) and the National Urban League (NUL), today announced the launch of the Walgreens Way to Well Health Tour with National Urban League as a charitable component of the Walgreens Way to Well Commitment®. The national tour will provide free health resources to residents in urban and minority communities who experience disproportionately higher rates of preventable disease. The service is free and insurance will not be billed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54971-walgreens-way-to-well-health-tour-with-nul
Peep! Peep! Thomas the Tank Engine™ fans were treated to quite a sight this morning as Thomas arrived to Brooklyn Bridge Park not by rail, but by sea. To mark the DVD release of the Thomas & Friends Misty Island Rescue from HIT Entertainment and the introduction of the newest Thomas toys from Fisher-Price, Inc. (a subsidiary of Mattel, Inc. (NASDAQ:MAT)) the companies joined together for a very special sneak preview.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/fisher-price/45525/
One of the most anticipated toys of the holiday season is hitting retail shelves today as Fisher-Price – a subsidiary of Mattel, Inc. (NASDAQ:MAT) – and Disney Consumer Products launch the innovative Dance Star Mickey plush that walks, talks, and grooves to a beat all his own.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/dancestarmickey/46426/
Activision Publishing, Inc. (Nasdaq: ATVI) announced today the worldwide debut of Skylanders Spyro’s Adventure, an entertainment breakthrough for the toy and video game industries. Through an innovative use of technology, the game allows players to transport real-world toys into virtual worlds of adventure through the “Portal of Power™.” These “toys with brains” can come to life inside the game in connection with multiple gaming platforms, as well as on handheld gaming devices, mobile devices and on the web, remembering achievements and level-ups wherever they go. This marks a wholesale change in the interaction between toys and video games, opening up new possibilities and revenue streams for both industries.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/skylandersgame/48523/
